Treatment Resistant Alcohol Use Disorder

被引:0
|
作者
Patterson Silver Wolf, David A. [1 ]
Dulmus, Catherine N. [2 ]
Wilding, Gregory E. [3 ]
Yu, Jihnhee [3 ]
Barczykowski, Amy L. [3 ]
Shi, Tiange [3 ]
Diebold, Josal R. [2 ]
Harvey, Steven J. [4 ]
Tomasello, Nicole M. [4 ]
Linn, Braden K. [2 ]
机构
[1] Washington Univ, Brown Sch, St Louis, MO 63110 USA
[2] Univ Buffalo, Sch Social Work, 221 Parker Hall, Buffalo, NY 14214 USA
[3] Univ Buffalo, Biostat, Buffalo, NY USA
[4] Ipa Inc, Integr Partners Behav Hlth, Batavia, NY USA
关键词
Alcohol use disorder; treatment recycling; recidivism; treatment resistance; risk factors; treatment-as-usual; NATIONAL EPIDEMIOLOGIC SURVEY; DEPRESSION; NALTREXONE; DRINKING; RISK;
D O I
10.1080/07347324.2021.1989994
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Despite existing interventions that have shown some promise for people with alcohol use disorder (AUD), there is a sizable number of patients that fail to respond to or complete treatment. In the current study, we analyzed data from the Treatment Episode Data Set (TEDS) to create profiles that indicate who may be more likely to resist treatment-as-usual. For the analysis, chi-square and logistic regression were used to associate personal characteristics with being at high and low risk of treatment resistance. Characteristics that put someone at higher risk of resisting treatment-as-usual include being unemployed, homelessness (or a dependent living arrangement), using daily, being male, and co-occurring mental and substance abuse disorders. The results suggest that general demographic information at patients' admission can be used to identify population groups where conventional strategies for standard AUD treatment may be insufficient. As such, the findings can help to inform, shape, and personalize treatment, leading to successful outcomes for the subgroup of individuals who will not benefit from typical AUD interventions.
引用
收藏
页码:205 / 216
页数:12
相关论文
共 50 条
  • [41] Effective Switch From Clozapine to Aripiprazole in Treatment-Resistant Schizophrenia and Comorbid Alcohol Use Disorder
    Feeley, Robert J.
    Arnaout, Bachaar
    Yoon, Gihyun
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2017, 37 (06) : 729 - 730
  • [42] EMOTION REGULATION TREATMENT FOR ALCOHOL USE DISORDER IMPROVES BOTH MENTAL HEALTH AND ALCOHOL USE DISORDER SYMPTOMS
    Linn, B. K.
    Stasiewicz, P. R.
    Slosman, K. S.
    Zhao, J.
    Ruszczyk, M. U.
    Lucke, J. F.
    Bradizza, C. M.
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2019, 43 : 129A - 129A
  • [43] Safety of nalmefene for the treatment of alcohol use disorder: an update
    Lopez-Pelayo, Hugo
    Zuluaga, Paola
    Caballeria, Elsa
    Van den Brink, Wim
    Mann, Karl
    Gual, Antoni
    EXPERT OPINION ON DRUG SAFETY, 2020, 19 (01) : 9 - 17
  • [44] NEZAVIST, A NOVEL MOLECULE FOR TREATMENT OF ALCOHOL USE DISORDER
    de Guglielmo, G.
    George, O.
    Borghese, C. M.
    Herman, M.
    Vanderlinden, L. A.
    Harris, R. A.
    Roberto, M.
    Roberts, A.
    Spanagel, R.
    Vengeliene, V.
    Hoffman, P. L.
    Tabakoff, B.
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2018, 42 : 148A - 148A
  • [45] Nutritional Ketosis as a Potential Treatment for Alcohol Use Disorder
    Mahajan, Vikrant R.
    Elvig, Sophie K.
    Vendruscolo, Leandro F.
    Koob, George F.
    Darcey, Valerie L.
    King, M. Todd
    Kranzler, Henry R.
    Volkow, Nora D.
    Wiers, Corinde E.
    FRONTIERS IN PSYCHIATRY, 2021, 12
  • [46] Topiramate Treatment of Alcohol Use Disorder in Clinical Practice
    Jefee-Bahloul, Hussam
    Jorandby, Lantie
    Arias, Albert J.
    JOURNAL OF ADDICTION MEDICINE, 2019, 13 (01) : 23 - 27
  • [47] Treatment trajectories for alcohol use disorder: Where is the gap?
    Mekonen, Tesfa
    Leung, Janni
    Chan, Gary C. K.
    Hides, Leanne
    Connor, Jason P.
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2021, 45 (08): : 1560 - 1562
  • [48] Exercise as treatment for alcohol use disorder: A qualitative study
    Gunillasdotter, Victoria
    Andreasson, Sven
    Hallgren, Mats
    Jirwe, Maria
    DRUG AND ALCOHOL REVIEW, 2022, 41 (07) : 1642 - 1652
  • [49] CLIENT EVALUATION OF TREATMENT FOR ALCOHOL USE DISORDER IN COMBINE
    Kirouac, M.
    Witkiewitz, K.
    Donovan, D.
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2016, 40 : 232A - 232A
  • [50] Baclofen for the treatment of alcohol use disorder: the Cagliari Statement
    Agabio, Roberta
    Sinclair, Julia M. A.
    Addolorato, Giovanni
    Aubin, Henri-Jean
    Beraha, Esther M.
    Caputo, Fabio
    Chick, Jonathan D.
    de La Selle, Patrick
    Franchitto, Nicolas
    Garbutt, James C.
    Haber, Paul S.
    Heydtmann, Mathis
    Jaury, Philippe
    Lingford-Hughes, Anne R.
    Morley, Kirsten C.
    Mueller, Christian A.
    Owens, Lynn
    Pastor, Adam
    Paterson, Louise M.
    Pelissier, Fanny
    Rolland, Benjamin
    Stafford, Amanda
    Thompson, Andrew
    van den Brink, Wim
    de Beaurepaire, Renaud
    Leggio, Lorenzo
    LANCET PSYCHIATRY, 2018, 5 (12): : 957 - 960